Okta (OKTA) Receives a Hold from Scotiabank
Scotiabank analyst Patrick Colville maintained a Hold rating on Okta (OKTA – Research Report) today and set a price target of $109.00. The ...
RBC Capital Reaffirms Their Hold Rating on Pliant Therapeutics (PLRX)
RBC Capital analyst Brian Abrahams maintained a Hold rating on Pliant Therapeutics (PLRX – Research Report) yesterday and set a price target of ...
Biogen (BIIB) Receives a Hold from Piper Sandler
In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...
Tempus AI, Inc. Class A (TEM) Receives a Hold from Piper Sandler
Piper Sandler analyst David Westenberg maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research Report) today and set a price target ...
Wells Fargo Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)
Wells Fargo analyst Tiago Fauth maintained a Hold rating on Pliant Therapeutics (PLRX – Research Report) today and set a price target of $3.00.
Piper Sandler Reaffirms Their Buy Rating on Cytek Biosciences (CTKB)
Piper Sandler analyst David Westenberg maintained a Buy rating on Cytek Biosciences (CTKB – Research Report) today and set a price target of ...
Piper Sandler Keeps Their Hold Rating on Myriad Genetics (MYGN)
In a report released today, David Westenberg from Piper Sandler maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...
Piper Sandler Remains a Buy on Upstream Bio, Inc. (UPB)
In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Upstream Bio, Inc. (UPB – Research Report), with a ...
Piper Sandler Sticks to Its Buy Rating for TransMedics Group (TMDX)
Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of ...
Steris (STE) Gets a Buy from Piper Sandler
In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Steris (STE – Research Report), with a price target of ...
Needham downgrades Pliant Therapeutics (PLRX) to a Hold
Pliant Therapeutics (PLRX – Research Report) received a Hold rating and price target from Needham analyst Joseph Stringer today. The ...
IFP Advisors Inc Raises Position in Robinhood Markets, Inc. (NASDAQ:HOOD)
IFP Advisors Inc boosted its stake in Robinhood Markets, Inc. (NASDAQ:HOOD – Free Report) by 601.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...